Form 4: Trevi Therapeutics CEO Jennifer Good Reports Stock Transactions
SEC Form 4 Filing
Trevi Therapeutics CEO Jennifer Good reports the exercise of stock options and subsequent sale of shares on May 10, 2024.
Summary
- On May 10, 2024, Jennifer Good, the President and CEO of Trevi Therapeutics, exercised stock options to acquire 4,578 shares of common stock at a price of $2.19 per share.
- Following the exercise of the options, Ms. Good sold 4,578 shares of common stock at a price of $2.9 per share.
- After these transactions, Ms. Good directly owns 213,313 shares of Trevi Therapeutics common stock, which includes 7,109 shares purchased through the company's employee stock purchase plan.
- Ms. Good also holds options to purchase 58,226 shares of common stock.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a standard Form 4 filing indicating insider stock transactions. The CEO exercised options and sold the shares, which could be for various personal financial reasons and doesn't necessarily indicate a positive or negative outlook on the company.
Industry Context
This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. Investors often monitor these filings for insights into management's perspective on the company's stock.
Key Dates
| Date | Description |
|---|---|
| 07/02/2014 | Date stock option was granted. |
| 06/11/2015 | 25% of the shares underlying the option vested. |
| 06/11/2018 | Remaining 75% of the shares vested in equal monthly installments. |
| 05/10/2024 | Date of stock option exercise and stock sale. |
| 05/14/2024 | Date of Form 4 filing. |
| 07/01/2024 | Expiration date of the stock option. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.